Literature DB >> 31433508

Phage resistance evolution in vitro is not reflective of in vivo outcome in a plant-bacteria-phage system.

Catherine A Hernandez1, Britt Koskella1.   

Abstract

The evolution of resistance to parasites is fundamentally important to disease ecology, yet we remain unable to predict when and how resistance will evolve. This is largely due to the context-dependent nature of host-parasite interactions, as the benefit of resistance will depend on the abiotic and biotic environment. Through experimental evolution of the plant pathogenic bacterium Pseudomonas syringae and two lytic bacteriophages across two different environments (high-nutrient media and the tomato leaf apoplast), we demonstrate that de novo evolution of resistance is negligible in planta despite high levels of resistance evolution in vitro. We find no evidence supporting the evolution of phage-selected resistance in planta despite multiple passaging experiments, multiple assays for resistance, and high multiplicities of infection. Additionally, we find that phage-resistant mutants (evolved in vitro) did not realize a fitness benefit over phage-sensitive cells when grown in planta in the presence of phage, despite reduced growth of sensitive cells, evidence of phage replication in planta, and a large fitness benefit in the presence of phage observed in vitro. Thus, this context-dependent benefit of phage resistance led to different evolutionary outcomes across environments. These results underscore the importance of studying the evolution of parasite resistance in ecologically relevant environments.
© 2019 The Author(s). Evolution © 2019 The Society for the Study of Evolution.

Entities:  

Keywords:  Bacteria; and resistance; experimental evolution; host-parasite; phage

Mesh:

Year:  2019        PMID: 31433508     DOI: 10.1111/evo.13833

Source DB:  PubMed          Journal:  Evolution        ISSN: 0014-3820            Impact factor:   3.694


  16 in total

1.  Taurine-Mediated IDOL Contributes to Resolution of Streptococcus uberis Infection.

Authors:  Zhixin Wan; Riguo Lan; Yilin Zhou; Yuanyuan Xu; Zhenglei Wang; Zhenhua Luo; Jinfeng Miao
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

Review 2.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

3.  High-throughput mapping of the phage resistance landscape in E. coli.

Authors:  Vivek K Mutalik; Benjamin A Adler; Harneet S Rishi; Denish Piya; Crystal Zhong; Britt Koskella; Elizabeth M Kutter; Richard Calendar; Pavel S Novichkov; Morgan N Price; Adam M Deutschbauer; Adam P Arkin
Journal:  PLoS Biol       Date:  2020-10-13       Impact factor: 8.029

4.  Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.

Authors:  James J Bull; Bruce R Levin; Ian J Molineux
Journal:  Viruses       Date:  2019-11-21       Impact factor: 5.048

5.  High viral abundance and low diversity are associated with increased CRISPR-Cas prevalence across microbial ecosystems.

Authors:  Sean Meaden; Ambarish Biswas; Ksenia Arkhipova; Sergio E Morales; Bas E Dutilh; Edze R Westra; Peter C Fineran
Journal:  Curr Biol       Date:  2021-11-09       Impact factor: 10.834

6.  Immune lag is a major cost of prokaryotic adaptive immunity during viral outbreaks.

Authors:  Jake L Weissman; Ellinor O Alseth; Sean Meaden; Edze R Westra; Jed A Fuhrman
Journal:  Proc Biol Sci       Date:  2021-10-20       Impact factor: 5.349

7.  Bacteriophage-Mediated Reduction of Bacterial Speck on Tomato Seedlings.

Authors:  Catherine A Hernandez; Andrea J Salazar; Britt Koskella
Journal:  Phage (New Rochelle)       Date:  2020-12-16

Review 8.  Engineered bacteriophages as programmable biocontrol agents.

Authors:  Phil Huss; Srivatsan Raman
Journal:  Curr Opin Biotechnol       Date:  2019-12-17       Impact factor: 9.740

Review 9.  Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.

Authors:  Mihnea R Mangalea; Breck A Duerkop
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

10.  Phage gene expression and host responses lead to infection-dependent costs of CRISPR immunity.

Authors:  Sean Meaden; Loris Capria; Ellinor Alseth; Sylvain Gandon; Ambarish Biswas; Luca Lenzi; Stineke van Houte; Edze R Westra
Journal:  ISME J       Date:  2020-10-03       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.